Prostate Cell News Volume 16.17 | Sep 12 2025

    0
    54







    2025-09-12 | PCN 16.17


    Prostate Cell News by STEMCELL Technologies
    Vol. 16.17 – 12 September, 2025
    TOP STORY

    Divergent FOXA1 Mutations Drive Prostate Tumorigenesis and Therapy-Resistant Cellular Plasticity

    Investigators developed and characterized genetically engineered mice with targeted knock-in of human cancer-associated FOXA1 Class 1 and Class 2 mutant transgenes.
    [Science]

    AbstractGraphical Abstract
    Subscribe to Science News for free weekly science newsletters.
    PUBLICATIONSListed by the impact factor of the journal

    Targeting TRPV6/CXCR4 Complexes Prevents Castration-Resistant Prostate Cancer Metastasis to the Bone

    Using a cohort of prostate cancer tissue biopsies from patients with a clinical history of at least 10 years after biopsy, scientists reported that TRPV6 expression directly correlates with CRPC tumor aggressiveness and increased risk of metastasis development.
    [Signal Transduction and Targeted Therapy]

    Full Article

    Localized High-Risk Prostate Cancer Harbors an Androgen Receptor Activity-Low Subpopulation Susceptible to HER2 Inhibition

    Baseline HER2 activity marks intrinsic resistance to neoadjuvant androgen deprivation therapy in localized high-risk prostate cancer and identifies a preexisting, targetable androgen receptor-low subpopulation.
    [Journal of Clinical Investigation]

    Abstract

    Enzalutamide-Resistant STEAP4+ MyoCAF Secrete Phosphatidylcholine to Foster Progression by Activating Stemness in Hormone-Sensitive Prostate Cancer

    Through comprehensive single-cell transcriptomic profiling of enzalutamide (ENZ)-naïve and ENZ-treated tumors, scientists identified an expansion of ENZ-resistant myofibroblastic cancer-associated fibroblasts that correlates with adverse clinical outcomes.
    [Advanced Science]

    Full Article

    Extracellular Domain Shedding of TROP2 Activates EGFR Signaling to Drive Prostate Cancer Metastasis

    While shed TROP2 extracellular domain did not affect prostate cancer cell proliferation and tumor growth, it increased cell migration and invasion in vitro and promoted metastatic colonization and spontaneous metastasis in vivo.
    [Cancer Research]

    Abstract

    Disrupting the Interaction between Androgen Receptor and Its Coregulator WDR77 Delays the Growth of Treatment-Resistant Prostate Cancer

    Researchers demonstrated the therapeutic potential of disrupting interactions between the androgen receptor and its coregulator WDR77. WDR77 stimulates prostate cancer growth, and its overexpression was associated with worse patient survival.
    [Cell Reports]

    Full ArticleGraphical Abstract
    Learn how to be a great STEM mentor to new lab members
    REVIEWS

    miRNA-Mediated Resistance Mechanisms in Prostate Cancer: Implications for Targeted Therapy and Metastatic Progression

    The authors present a novel, mechanism-centered synthesis focused specifically on miRNA-mediated resistance pathways across standard treatment modalities, including androgen deprivation therapy, enzalutamide, docetaxel, and radiotherapy.
    [Medical Oncology]

    Abstract
    INDUSTRY AND POLICY NEWS

    EDAP Receives HIFU Reimbursement for Prostate Cancer in France

    EDAP TMS announced that the French Ministry of Health has awarded reimbursement for High Intensity Focused Ultrasound (HIFU) procedure for the treatment of prostate cancer in France.
    [EDAP TMS (BioSpace)]

    Press Release
    FEATURED EVENT

    Organoids: Modeling Organ Development and Disease in 3D

    October 22-25, 2025
    Heidelberg, Germany & Online

    > See All Events

    JOB OPPORTUNITIES

    Research Associate in AI and Medical Imaging – Prostate Cancer

    King’s College London – London, England, United States

    Assistant/Associate/Senior Scientist – Cancer Research

    Henry Ford Health + Michigan State – Detroit, Michigan, United States

    Assistant Research Scientist – Prostate and Kidney Cancer

    University of Michigan – Michigan, Ann Arbor, United States

    Senior Research Associate – Prostate Cancer Health Services Research

    University of Bristol – Bristol, England, United Kingdom

    Post Doctoral Research Associate – Abscopal effect in Prostate Cancer

    Imperial College London – London, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2